MedTrace Logo

Low-dose Intravenous Dexamethasone at Different Times as Adjunvants for Brachial Plexus Blocks

NCT04714112 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2023-01-26

No results posted yet for this study

Summary

Dexamethasone has been tested as an effective adjuvant to prolong the effect of local anesthetics for peripheral nerve blocks, both perineurally and intravenously. The purpose of this study is to investigate the effect of the addition of dexamethasone (5mg) at different time to a standard ropivacaine solution (0.5%) on analgesic duration of interscalene block.

Conditions

  • Analgesia
  • Dexamethasone
  • Brachial Plexus Block
  • Intravenous Drug Usage
  • Time
  • Shoulder Surgery

Interventions

DRUG

dexamethasone

Intravenous administration of dexamethasone at different time for the duration of ISB with 0.5% ropivacaine

Sponsors & Collaborators

  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital

    lead OTHER

Principal Investigators

  • Quanhong Zhou, MD., Ph.D · Shanghai Jiaotong University affiliated Shanghai Sixth People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-10
Primary Completion
2021-05-31
Completion
2021-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04714112 on ClinicalTrials.gov